中国寄生虫学与寄生虫病杂志 ›› 2000, Vol. 18 ›› Issue (4): 9-226.

• 论著 • 上一篇    下一篇

免疫缺陷性疾病患者弓形虫抗体的调查

王宝林;潘孝彰;尹有宽;翁心华
  

  1. 上海医科大学华山医院!上海200040
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2000-08-30 发布日期:2000-08-30

INVESTIGATION OF ANTI- TOXOPLASMA GONDII ANTIBODIES IN IMMUNODEFICIENT PATIENTS

WANG Bao-lin;PAN Xiao-zhang;YIN You-kuan;WENG Xin-hua   

  1. Huashan Hospital;Shanghai Medical University;Shanghai 200040
  • Received:1900-01-01 Revised:1900-01-01 Online:2000-08-30 Published:2000-08-30

摘要:   [目的 ]调查免疫缺陷性疾病患者弓形虫IgG抗体的阳性率。 [方法 ]以酶联免疫吸附试验 (ELISA)检测临床多种免疫缺陷性疾病 ,包括实体性恶性肿瘤 (消化系统恶性肿瘤未化疗组、实体性恶性肿瘤未化疗组及实体性恶性肿瘤化疗组 )、慢性肝病、接受免疫抑制剂者 (皮肌炎、银屑病、天疱疮、肾移植术后、系统性红斑狼疮及其它使用免疫抑制剂者 )及血液系统恶性肿瘤 (淋巴瘤及白血病 )患者血清标本共 371份 ,同时以 10 0例健康人血清为对照。 [结果与结论 ]实体性恶性肿瘤接受化疗者、接受肾移植者、慢性肝病、系统性红斑狼疮及白血病患者抗弓形虫IgG抗体阳性率分别为 19 0 %、 33 3%、 16 5 %、 45 5 %及 2 0 0 % ,与对照组相比较 ,其差异均具有显著性意义 (P <0 0 5 )。以上疾病的患者有继发弓形虫病的高度危险。

关键词: 免疫缺陷, 弓形虫病, 酶联免疫吸附试验

Abstract:  Objective] To investigate the presence of anti- Toxoplasma gondii antibodies in immunodeficient patients. [Methods] T gondii -specific immunoglobulin G (IgG) antibodies in serum samples from 371 immunodeficient patients were detected by enzyme-linked immunosorbent assay (ELISA). The patients were with solid malignancies (including untreated digestive system malignancies and solid malignancies received chemotherapy), chronic liver diseases, patients received immunosuppressant therapy (dermatomyositis, psoriasis, pemphigus, post-renal transplantation, systemic lupus erythematosus and other miscellanies), lymphoma, leukemia and diabetes. 100 normal serum samples served as controls. [Results] The positive rate of patients with solid malignancies received chemotherapy, solid malignancies received chemotherapy, chronic liver diseases, systemic lupus erythematosus and leukemia was 19 0%, 33 3%, 16 5%, 45 4% and 20 0%, respectively,being significantly higher than that of the control group( P <0 05). [Conclusion] The immunosuppressed patients are highly predisposing to secondary T.gondii infection .

Key words: immunodeficient, toxoplasmosis, enzyme-linked immunosorbent assay (ELISA)